These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1176 related articles for article (PubMed ID: 18310456)
1. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
2. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Mukai T; Otsuka F; Otani H; Yamashita M; Takasugi K; Inagaki K; Yamamura M; Makino H Biochem Biophys Res Commun; 2007 May; 356(4):1004-10. PubMed ID: 17397798 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945 [TBL] [Abstract][Full Text] [Related]
5. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880 [TBL] [Abstract][Full Text] [Related]
6. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987 [TBL] [Abstract][Full Text] [Related]
7. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428 [TBL] [Abstract][Full Text] [Related]
8. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. Kuo PL; Hsu YL; Chang CH; Chang JK J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019 [TBL] [Abstract][Full Text] [Related]
9. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. Hsu YL; Kuo PL J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307 [TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2. Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788 [TBL] [Abstract][Full Text] [Related]
11. M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation. Watanabe-Takano H; Takano K; Keduka E; Endo T Exp Cell Res; 2010 Feb; 316(3):477-90. PubMed ID: 19800879 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655 [TBL] [Abstract][Full Text] [Related]
13. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. Korchynskyi O; Dechering KJ; Sijbers AM; Olijve W; ten Dijke P J Bone Miner Res; 2003 Jul; 18(7):1177-85. PubMed ID: 12854827 [TBL] [Abstract][Full Text] [Related]
15. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Lee KS; Hong SH; Bae SC Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805 [TBL] [Abstract][Full Text] [Related]
16. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation. Huang RL; Yuan Y; Tu J; Zou GM; Li Q Cell Death Dis; 2014 Apr; 5(4):e1187. PubMed ID: 24743742 [TBL] [Abstract][Full Text] [Related]
17. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945 [TBL] [Abstract][Full Text] [Related]
19. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]